The three insulin response sequences in the glucose-6-phosphatase catalytic subunit gene promoter are functionally distinct

J Biol Chem. 2003 Apr 4;278(14):11782-93. doi: 10.1074/jbc.M212570200. Epub 2003 Jan 28.

Abstract

Glucose-6-phosphatase catalyzes the terminal step in the gluconeogenic and glycogenolytic pathways. In HepG2 cells, the maximum repression of basal glucose-6-phosphatase catalytic subunit (G6Pase) gene transcription by insulin requires two distinct promoter regions, designated A (located between -231 and -199) and B (located between -198 and -159), that together form an insulin response unit. Region A binds hepatocyte nuclear factor-1, which acts as an accessory factor to enhance the effect of insulin, mediated through region B, on G6Pase gene transcription. We have previously shown that region B binds the transcriptional activator FKHR (FOXO1a) in vitro. Chromatin immunoprecipitation assays demonstrate that FKHR also binds the G6Pase promoter in situ and that insulin inhibits this binding. Region B contains three insulin response sequences (IRSs), designated IRS 1, 2, and 3, that share the core sequence T(G/A)TTTT. However, detailed analyses reveal that these three G6Pase IRSs are functionally distinct. Thus, FKHR binds IRS 1 with high affinity and IRS 2 with low affinity but it does not bind IRS 3. Moreover, in the context of the G6Pase promoter, IRS 1 and 2, but not IRS 3, are required for the insulin response. Surprisingly, IRS 3, as well as IRS 1 and IRS 2, can each confer an inhibitory effect of insulin on the expression of a heterologous fusion gene, indicating that, in this context, a transcription factor other than FKHR, or its orthologs, can also mediate an insulin response through the T(G/A)TTTT motif.

Publication types

  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Animals
  • Base Sequence
  • Carcinoma, Hepatocellular
  • Catalytic Domain / genetics*
  • Chloramphenicol O-Acetyltransferase / genetics
  • DNA-Binding Proteins / metabolism
  • Forkhead Box Protein O1
  • Forkhead Transcription Factors
  • Gene Expression Regulation, Enzymologic / drug effects
  • Gene Expression Regulation, Enzymologic / physiology
  • Glucose-6-Phosphatase / genetics*
  • Humans
  • Hypoglycemic Agents / pharmacology*
  • Insulin / pharmacology*
  • Insulin-Like Growth Factor Binding Protein 1 / genetics
  • Insulin-Like Growth Factor Binding Protein 1 / metabolism
  • Mice
  • Nerve Tissue Proteins*
  • Promoter Regions, Genetic / genetics*
  • Rats
  • Recombinant Fusion Proteins / genetics
  • Transcription Factors / metabolism
  • Transcriptional Activation / drug effects
  • Transcriptional Activation / physiology
  • Tumor Cells, Cultured

Substances

  • DNA-Binding Proteins
  • FOXO1 protein, human
  • Forkhead Box Protein O1
  • Forkhead Transcription Factors
  • Foxo1 protein, mouse
  • Hypoglycemic Agents
  • Insulin
  • Insulin-Like Growth Factor Binding Protein 1
  • Nerve Tissue Proteins
  • Recombinant Fusion Proteins
  • Transcription Factors
  • Foxo1 protein, rat
  • Chloramphenicol O-Acetyltransferase
  • Glucose-6-Phosphatase